Last reviewed · How we verify

Glucophage — Competitive Intelligence Brief

Glucophage (Glucophage) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Metabolic.

marketed 5'-AMP-activated protein kinase subunit beta-1, Solute carrier family 22 member 1, Solute carrier family 22 member 2 Metabolic Small molecule Live · refreshed every 30 min

Target snapshot

Glucophage (Glucophage) — Dr. Reddy's Laboratories Limited.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Glucophage TARGET Glucophage Dr. Reddy's Laboratories Limited marketed 5'-AMP-activated protein kinase subunit beta-1, Solute carrier family 22 member 1, Solute carrier family 22 member 2
Glucophage metformin Generic (originally Merck Serono/Lipha) marketed Dipeptidyl Peptidase 4 Inhibitor [EPC] 5'-AMP-activated protein kinase subunit beta-1, Solute carrier family 22 member 1, Solute carrier family 22 member 2 1995-03-03

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Glucophage — Competitive Intelligence Brief. https://druglandscape.com/ci/glucophage. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators: